角膜架橋デバイス市場 : 2030年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2022年12月

Corneal Cross linking Devices Market Forecast till 2030
角膜架橋デバイス市場 : 2030年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Corneal Cross linking Devices Market Forecast till 2030

Market Overview

According to the MRFR investigation, the Corneal cross linking Devices market is supposed to enroll a healthy CAGR of 13.86%. Riboflavin eye drops and a UV light source are both utilized in this method. The collagen particles and proteoglycans interface due to the photochemical response. The rising rate and commonness of keratoconus sicknesses and the extension of the healthcare framework are anticipated to be the primary drivers of the worldwide market for CXL devices. The absence of mindfulness and treatment-related secondary effects, nonetheless, are supposed to restrict market development.
Due to the rising elderly population, the incidence of keratoconus conditions, and the concentration of key market players in the area, North America is predicted to dominate the market. The demand for CXL devices in Europe is rising because of the rise in keratoconus patients in industrialized nations. The market is expanding in Europe because of rising keratoconus prevalence and its consequent rise, technological improvements in medicine, and rising demand for CXL devices.
Market Segmentation
Based on type, method, application, and end-user, the market for corneal cross linking devices has been segmented globally. The market is divided into accelerated cross-linking, conventional corneal cross-linking, and corneal cross-linking plus based on type.
The epithelium-off method and the epithelium-on method are two market segments based on the method. The global market for corneal cross linking devices has been divided into categories based on application, including keratoconus, pellucid marginal degeneration, refractive surgery ectasia, and others. The global market for corneal cross linking devices has been divided into hospitals, eye clinics, and ambulatory surgery centers based on end users.
Regional Analysis
Based on region, the market for corneal cross connecting devices has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Due to the rising elderly population, the incidence of keratoconus conditions, and the concentration of key market players in the area, North America is predicted to dominate the market. The demand for CXL devices in Europe is rising because of the rise in keratoconus patients in industrialized nations. The European market expansion is attributed to the growing keratoconus prevalence and its consequent rise, technological improvements in medicine, and rising demand for CXL devices. Attributable to the developing predominance of instances of eye problems is driving the market development in the Asia-Pacific area. Organizations are going into key drives to create and market new treatment choices for patients. The remainder of the world represented the least market share in the corneal cross linking gadgets market. This is credited to less accessibility of assets and restricted clinical offices in the locale.
Key Players
The prominent players in the global Corneal Cross linking devices market include EMAGine AG (Switzerland), Glaukos Corporation (US), Peschke GmbH (Switzerland), iVIS Technologies (Italy), IROMED GROUP Srl (Italy), and AJL Ophthalmic S.A. (Spain).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING INCIDENCE AND PREVALENCE OF KERATOCONUS DISORDERS

4.2.2 IMPROVING HEALTHCARE INFRASTRUCTURE

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS REGARDING KERATOCONUS DISORDERS

4.3.2 SIDE EFFECTS ASSOCIATED WITH TREATMENT

4.4 OPPORTUNITIES

4.4.1 INCREASING PRODUCT DEVELOPMENT AND LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON MARKET PLAYERS

5.4 REIMBURESEMENT SCENARIO FOR CXL PROCEDURES

6 GLOBAL RIBOFLAVIN SOLUTIONS MARKET SIZE AND STATISTICS

6.1 OVERVIEW

7 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE

7.1 OVERVIEW

7.2 STANDARD CORNEAL CROSS LINKING

7.3 CORNEAL CROSS-LINKING PLUS

7.4 ACCELERATED CROSS-LINKING

8 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD

8.1 OVERVIEW

8.2 EPITHELIUM-OFF METHOD

8.3 EPITHELIUM-ON METHOD

9 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 KERATOCONUS

9.3 PELLUCID MARGINAL DEGENERATION

9.4 REFRACTIVE SURGERY ECTASIA

9.5 OTHERS

10 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 EYE CLINICS

10.4 AMBULATORY SURGICAL CENTERS

11 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 UK

11.3.3 FRANCE

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET: COMPANY SHARE ANALYSIS

12.4 MAJOR GROWTH STRATEGY IN GLOBALCORNEAL CROSS-LINKING (CXL) DEVICES MARKET

12.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

12.6 KEY DEVELOPMENT ANALYSIS

12.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.7.1 PARTNERSHIP/COLLABORATION

12.7.2 MERGERS & ACQUISITIONS

13 COMPANY PROFILE

13.1 GLAUKOS CORPORATION

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 PRODUCTS OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 EMAGINE AG

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 PRODUCTS OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 IVIS TECHNOLOGIES

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 PRODUCTS OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 KEY STRATEGIES

13.4 IROMED GROUP SRL

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 PRODUCTS OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 KEY STRATEGIES

13.5 PESCHKE GMBH

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 PRODUCTS OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 AJL OPHTHALMIC S.A.

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 PRODUCTS OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLBOAL KERATOCONUS EPIDEMIOLOGY

TABLE 4 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR RIBOFLAVIN SOLUTIONS, BY REGION, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR STANDARD CORNEAL CROSS-LINKING, BY REGION, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR CORNEAL CROSS-LINKING PLUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR ACCELERATED CROSS-LINKING, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 10 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EPITHELIUM-OFF METHOD, BY REGION, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EPITHELIUM-ON METHOD, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR KERATOCONUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 14 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR PELLUCID MARGINAL DEGENERATION, BY REGION, 2018–2030 (USD MILLION)

TABLE 15 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR REFRACTIVE SURGERY ECTASIA, BY REGION, 2018–2030 (USD MILLION)

TABLE 16 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 17 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 18 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR HOSPITALS, BY REGION, 2018–2030 (USD MILLION)

TABLE 19 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EYE CLINICS, BY REGION, 2018–2030 (USD MILLION)

TABLE 20 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 21 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 22 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 23 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 24 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 25 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 26 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 27 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 28 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 29 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 30 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 31 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 32 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 33 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 34 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 35 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 36 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 37 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 38 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 39 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 40 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 41 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 42 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 43 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 44 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 45 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 46 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 47 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 48 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 49 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 50 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 51 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 52 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 53 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 54 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 55 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 56 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 57 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 58 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 59 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 60 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 61 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)

TABLE 62 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 63 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 64 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 65 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 66 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 67 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 68 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 69 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 70 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 71 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 72 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 73 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 74 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 75 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 76 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 77 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 78 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 79 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 80 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 81 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 82 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 83 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 84 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 85 SOUTH KOREA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 86 SOUTH KOREA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 87 SOUTH KOREA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 88 SOUTH KOREA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 89 REST OF ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 90 REST OF ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 91 REST OF ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 92 REST OF ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 93 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY 2018–2030 (USD MILLION)

TABLE 94 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 95 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 96 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 97 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 98 MIDDLE EAST: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 99 MIDDLE EAST: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 100 MIDDLE EAST: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 101 MIDDLE EAST: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 102 AFRICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 103 AFRICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 104 AFRICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 105 AFRICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 106 LATIN AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 107 LATIN AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)

TABLE 108 LATIN AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 109 LATIN AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 110 MAJOR MANUFACTURERS IN GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

TABLE 111 MOST ACTIVE PLAYER IN CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

TABLE 112 PARTNERSHIP/COLLABORATION

TABLE 113 MERGERS & ACQUISITIONS

TABLE 114 GLAUKOS CORPORATION: PRODUCTS OFFERED

TABLE 115 GLAUKOS CORPORATION: KEY DEVELOPMENTS

TABLE 116 EMAGINE AG: PRODUCTS OFFERED

TABLE 117 IVIS TECHNOLOGIES: PRODUCTS OFFERED

TABLE 118 IROMED GROUP SRL: PRODUCTS OFFERED

TABLE 119 IROMED GROUP SRL: KEY DEVELOPMENTS

TABLE 120 PESCHKE GMBH: PRODUCTS OFFERED

TABLE 121 AJL OPHTHALMIC S.A.: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

FIGURE 9 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2021 & 2030 (USD MILLION)

FIGURE 10 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2021 & 2030 (USD MILLION)

FIGURE 11 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2021 & 2030 (USD MILLION)

FIGURE 12 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2021 & 2030 (USD MILLION)

FIGURE 13 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION 2021 & 2030 (USD MILLION)

FIGURE 14 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET SHARE (%), BY REGION 2021

FIGURE 15 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 16 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 17 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 18 REST OF THE WORLD: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR MANUFACTURER MARKET SHARE ANALYSIS, 2021

FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET

FIGURE 22 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET: COMPETITIVE LANDSCAPE

FIGURE 23 GLAUKOS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 GLAUKOS CORPORATION: SWOT ANALYSIS

FIGURE 25 EMAGINE AG: SWOT ANALYSIS

FIGURE 26 PESCHKE GMBH: SWOT ANALYSIS